Shire Human Genetic Therapies AB

ABDissolved

Org 5565911764Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20003 employees

Overview Financials People & ownership Related companies

Shire Human Genetic Therapies AB is a Swedish AB, operating in the Partihandel med medicinsk utrustning och apoteksvaror sector. Incorporated in 2000, the company has 3 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2025

SEK 0

EBITDA margin

—

-51% vs 2024

Equity ratio

99.4%

Financial strength

Net profit 2025

SEK 354K

-54% vs 2024

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 0	—
EBITDA	SEK 476K	-51%
Net profit	SEK 354K	-54%
Total assets	SEK 26,7M	+1%
Equity	SEK 26,5M	+1%
Employees	3	—

Contact

Address

Phone

+46854496400

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Shire Human Genetic Therapies AB?

Shire Human Genetic Therapies AB is registered with Bolagsverket / SCB under Org 5565911764.

How many employees does Shire Human Genetic Therapies AB have?

Shire Human Genetic Therapies AB employs 3 people as of the latest annual report.

Who is the CEO of Shire Human Genetic Therapies AB?

Anders Joakim Toivo Taaler is Chief Auditor of Shire Human Genetic Therapies AB, in role since 2022.

Who is the chairman of Shire Human Genetic Therapies AB?

Roland Kurney chairs the board of Shire Human Genetic Therapies AB, in role since 2025.

Shire Human Genetic Therapies AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Shire Human Genetic Therapies AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Shire Human Genetic Therapies AB